Literature DB >> 24295983

Pathogenicity of clinical Acinetobacter baumannii isolates in a Galleria mellonella host model according to bla(OXA-40) gene and epidemiological outbreak status.

John S Esterly1, Milena M McLaughlin, Michael Malczynski, Chao Qi, Teresa R Zembower, Marc H Scheetz.   

Abstract

Clinical studies have suggested that blaOXA-40-positive Acinetobacter baumannii isolates are associated with poor patient outcomes; however, reasons for unfavorable outcomes are difficult to discern in clinical studies. The objective of this study was to assess the virulence of carbapenem-resistant A. baumannii according to blaOXA-40 and epidemiological outbreak status in a Galleria mellonella model. Eight isolates of A. baumannii were studied. Nonoutbreak isolates and blaOXA-40-negative isolates more rapidly killed infected G. mellonella (P < 0.01).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24295983      PMCID: PMC3910851          DOI: 10.1128/AAC.02201-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia.

Authors:  Christopher W Woods; Adam M Bressler; John J LiPuma; Barbara D Alexander; Dennis A Clements; David J Weber; Christopher M Moore; L Barth Reller; Keith S Kaye
Journal:  Clin Infect Dis       Date:  2004-04-15       Impact factor: 9.079

2.  A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.

Authors:  Wang-Huei Sheng; Chun-Hsing Liao; Tsai-Ling Lauderdale; Wen-Chien Ko; Yao-Shen Chen; Jien-Wei Liu; Yeu-Jun Lau; Li-Hsin Wang; Ke-Sun Liu; Tung-Yuan Tsai; San-Yi Lin; Meng-Shiuan Hsu; Le-Yin Hsu; Shan-Chwen Chang
Journal:  Int J Infect Dis       Date:  2010-06-19       Impact factor: 3.623

3.  Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007.

Authors:  Chao Qi; Michael Malczynski; Michelle Parker; Marc H Scheetz
Journal:  J Clin Microbiol       Date:  2008-01-23       Impact factor: 5.948

4.  Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects.

Authors:  G Jander; L G Rahme; F M Ausubel
Journal:  J Bacteriol       Date:  2000-07       Impact factor: 3.490

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.

Authors:  C Routsi; M Pratikaki; E Platsouka; C Sotiropoulou; S Nanas; V Markaki; C Vrettou; O Paniara; H Giamarellou; C Roussos
Journal:  Infection       Date:  2010-03-12       Impact factor: 3.553

7.  Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis.

Authors:  Eleftherios Mylonakis; Roberto Moreno; Joseph B El Khoury; Alexander Idnurm; Joseph Heitman; Stephen B Calderwood; Frederick M Ausubel; Andrew Diener
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

8.  Identification of resistance and virulence factors in an epidemic Enterobacter hormaechei outbreak strain.

Authors:  Armand Paauw; Martien P M Caspers; Maurine A Leverstein-van Hall; Frank H J Schuren; Roy C Montijn; Jan Verhoef; Ad C Fluit
Journal:  Microbiology       Date:  2009-04-16       Impact factor: 2.777

9.  Virulence of vancomycin-resistant Enterococcus faecium according to linezolid resistance and clinical outbreak status.

Authors:  Milena McLaughlin; Michael Malczynski; Chao Qi; Grace Barajas; Jordan Radetski; Teresa Zembower; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

10.  Characterization of Acinetobacter baumannii genotypes recovered from patients with repeated colonization or infection.

Authors:  Chao Qi; Marc H Scheetz; Michael Malczynski
Journal:  Diagn Microbiol Infect Dis       Date:  2009-09       Impact factor: 2.803

View more
  4 in total

Review 1.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Multiple roles for a novel RND-type efflux system in Acinetobacter baumannii AB5075.

Authors:  Kyle A Tipton; Marjan Farokhyfar; Philip N Rather
Journal:  Microbiologyopen       Date:  2016-10-19       Impact factor: 3.139

Review 3.  Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing.

Authors:  Catherine Jia-Yun Tsai; Jacelyn Mei San Loh; Thomas Proft
Journal:  Virulence       Date:  2016-01-05       Impact factor: 5.882

4.  Comparative analysis of the pathogenicity between multidrug-resistant Acinetobacter baumannii clinical isolates: isolation of highly pathogenic multidrug-resistant A. baumannii and experimental therapeutics with fourth-generation cephalosporin cefozopran.

Authors:  Satoshi Nishida; Yasuo Ono
Journal:  Infect Drug Resist       Date:  2018-10-10       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.